Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy

Experimental Cell Research

Volumn 316, Issue 18, 2010, Pages 3100-3108

  Morgan, Jennifer E ^a   Zammit, Peter S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Congenital muscular dystrophy; Muscular dystrophy; Satellite cell; Skeletal muscle; Stem cell

Indexed keywords

CELL ACTIVITY; CELL FUNCTION; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; MUSCLE ATROPHY; MUSCLE EYE BRAIN DISEASE; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE SATELLITE CELL; ANIMAL; GENETICS; MUTATION; PATHOLOGY;

ANIMALS; HUMANS; MUSCULAR DYSTROPHIES; MUTATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 77957665581     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.05.014     Document Type: Review

References (68)

1. Emery A.E. The muscular dystrophies. Lancet 2002, 359:687-695.
2. Moss F.P., Leblond C.P. Satellite cells as the source of nuclei in muscles of growing rats. Anat. Rec. 1971, 170:421-435.
3. Schultz E., Gibson M.C., Champion T. Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J. Exp. Zool. 1978, 206:451-456.
4. Mauro A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 1961, 9:493-495.
5. Zammit P.S. All muscle satellite cells are equal, but are some more equal than others?. J. Cell Sci. 2008, 121:2975-2982.
6. Allikian M.J., McNally E.M. Processing and assembly of the dystrophin glycoprotein complex. Traffic 2007, 8:177-183.
7. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
8. Sandona D., Betto R. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev. Mol. Med. 2009, 11:e28.
9. Webster C., Blau H.M. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat. Cell. Mol. Genet. 1990, 16:557-565.
10. Decary S., Hamida C.B., Mouly V., Barbet J.P., Hentati F., Butler-Browne G.S. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 2000, 10:113-120.
11. Wakeford S., Watt D.J., Partridge T.A. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 1991, 14:42-50.
12. Ono Y., Boldrin L., Knopp P., Morgan J.E., Zammit P.S. Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev. Biol. 2010, 337:29-41.
13. Cohn R.D., Henry M.D., Michele D.E., Barresi R., Saito F., Moore S.A., Flanagan J.D., Skwarchuk M.W., Robbins M.E., Mendell J.R., Williamson R.A., Campbell K.P. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 2002, 110:639-648.
14. Spalding K.L., Bhardwaj R.D., Buchholz B.A., Druid H., Frisen J. Retrospective birth dating of cells in humans. Cell 2005, 122:133-143.
15. Kamminga L.M., van Os R., Ausema A., Noach E.J., Weersing E., Dontje B., Vellenga E., de Haan G. Impaired hematopoietic stem cell functioning after serial transplantation and during normal aging. Stem Cells 2005, 23:82-92.
16. Sewry C.A., Jimenez-Mallebrera C., Muntoni F. Congenital myopathies. Curr. Opin. Neurol. 2008, 21:569-575.
17. Jimenez-Mallebrera C., Torelli S., Feng L., Kim J., Godfrey C., Clement E., Mein R., Abbs S., Brown S.C., Campbell K.P., Kroger S., Talim B., Topaloglu H., Quinlivan R., Roper H., Childs A.M., Kinali M., Sewry C.A., Muntoni F. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol. 2009, 19:596-611.
18. Schuler F., Sorokin L.M. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J. Cell Sci. 1995, 108(Pt 12):3795-3805.
19. Kuang W., Xu H., Vilquin J.T., Engvall E. Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency. Lab. Invest. 1999, 79:1601-1613.
20. Girgenrath M., Dominov J.A., Kostek C.A., Miller J.B. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J. Clin. Invest. 2004, 114:1635-1639.
21. Girgenrath M., Kostek C.A., Miller J.B. Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. BMC Neurol. 2005, 5:7.
22. Vachon P.H., Loechel F., Xu H., Wewer U.M., Engvall E. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J. Cell Biol. 1996, 134:1483-1497.
23. Hayashi Y.K., Chou F.L., Engvall E., Ogawa M., Matsuda C., Hirabayashi S., Yokochi K., Ziober B.L., Kramer R.H., Kaufman S.J., Ozawa E., Goto Y., Nonaka I., Tsukahara T., Wang J.Z., Hoffman E.P., Arahata K. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat. Genet. 1998, 19:94-97.
24. Mayer U., Saher G., Fassler R., Bornemann A., Echtermeyer F., von der Mark H., Miosge N., Poschl E., von der Mark K. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat. Genet. 1997, 17:318-323.
25. Gnocchi V.F., White R.B., Ono Y., Ellis J.A., Zammit P.S. Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells. PLoS ONE 2009, 4:e5205.
26. Muntoni F., Torelli S., Brockington M. Muscular dystrophies due to glycosylation defects. Neurotherapeutics 2008, 5:627-632.
27. Cohen T.V., Stewart C.L. Fraying at the edge mouse models of diseases resulting from defects at the nuclear periphery. Curr. Top. Dev. Biol. 2008, 84:351-384.
28. Miyagoe-Suzuki Y., Masubuchi N., Miyamoto K., Wada M.R., Yuasa S., Saito F., Matsumura K., Kanesaki H., Kudo A., Manya H., Endo T., Takeda S. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech. Dev. 2009, 126:107-116.
29. Ackroyd M.R., Skordis L., Kaluarachchi M., Godwin J., Prior S., Fidanboylu M., Piercy R.J., Muntoni F., Brown S.C. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2009, 132:439-451.
30. Holzfeind P.J., Grewal P.K., Reitsamer H.A., Kechvar J., Lassmann H., Hoeger H., Hewitt J.E., Bittner R.E. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet. 2002, 11:2673-2687.
31. Scharner J., Gnocchi V.F., Ellis J.A., Zammit P.S. Genotype-phenotype correlations in laminopathies: how does fate translate?. Biochem. Soc. Trans. 2010, 38:257-262.
32. Capell B.C., Collins F.S. Human laminopathies: nuclei gone genetically awry. Nat. Rev. Genet. 2006, 7:940-952.
33. Worman H.J., Courvalin J.C. How do mutations in lamins A and C cause disease?. J. Clin. Invest. 2004, 113:349-351.
34. Holaska J.M., Wilson K.L. Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2006, 288:676-680.
35. Markiewicz E., Ledran M., Hutchison C.J. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J. Cell Sci. 2005, 118:409-420.
36. De Falco G., Comes F., Simone C. pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene 2006, 25:5244-5249.
37. Bakay M., Wang Z., Melcon G., Schiltz L., Xuan J., Zhao P., Sartorelli V., Seo J., Pegoraro E., Angelini C., Shneiderman B., Escolar D., Chen Y.W., Winokur S.T., Pachman L.M., Fan C., Mandler R., Nevo Y., Gordon E., Zhu Y., Dong Y., Wang Y., Hoffman E.P. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006, 129:996-1013.
38. Favreau C., Higuet D., Courvalin J.C., Buendia B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol. Cell. Biol. 2004, 24:1481-1492.
39. Frock R.L., Kudlow B.A., Evans A.M., Jameson S.A., Hauschka S.D., Kennedy B.K. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev. 2006, 20:486-500.
40. Melcon G., Kozlov S., Cutler D.A., Sullivan T., Hernandez L., Zhao P., Mitchell S., Nader G., Bakay M., Rottman J.N., Hoffman E.P., Stewart C.L. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum. Mol. Genet. 2006, 15:637-651.
41. Abu-Baker A., Rouleau G.A. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim. Biophys. Acta 2007, 1772:173-185.
42. Perie S., Mamchaoui K., Mouly V., Blot S., Bouazza B., Thornell L.E., St Guily J.L., Butler-Browne G. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: therapeutic perspectives of autologous myoblast transplantation. Neuromuscul. Disord. 2006, 16:770-781.
43. Davies J.E., Wang L., Garcia-Oroz L., Cook L.J., Vacher C., O'Donovan D.G., Rubinsztein D.C. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat. Med. 2005, 11:672-677.
44. Hino H., Araki K., Uyama E., Takeya M., Araki M., Yoshinobu K., Miike K., Kawazoe Y., Maeda Y., Uchino M., Yamamura K. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 2004, 13:181-190.
45. Wang Q., Bag J. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis. Biochem. Biophys. Res. Commun. 2006, 340:815-822.
46. Apponi L.H., Leung S.W., Williams K.R., Valentini S.R., Corbett A.H., Pavlath G.K. Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis. Hum. Mol. Genet. 2010, 19:1058-1065.
47. Harel I., Nathan E., Tirosh-Finkel L., Zigdon H., Guimaraes-Camboa N., Evans S.M., Tzahor E. Distinct origins and genetic programs of head muscle satellite cells. Dev. Cell 2009, 16:822-832.
48. Barro M., Carnac G., Flavier S., Mercier J., Vassetzky Y., Laoudj-Chenivesse D. Myoblasts from affected and non affected FSHD muscles exhibit morphological differentiation defects. J. Cell. Mol. Med. 2008, 14:275-289.
49. Winokur S.T., Barrett K., Martin J.H., Forrester J.R., Simon M., Tawil R., Chung S.A., Masny P.S., Figlewicz D.A. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord. 2003, 13:322-333.
50. Winokur S.T., Chen Y.W., Masny P.S., Martin J.H., Ehmsen J.T., Tapscott S.J., van der Maarel S.M., Hayashi Y., Flanigan K.M. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 2003, 12:2895-2907.
51. van Deutekom J.C., Wijmenga C., van Tienhoven E.A., Gruter A.M., Hewitt J.E., Padberg G.W., van Ommen G.J., Hofker M.H., Frants R.R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2kb tandemly repeated unit. Hum. Mol. Genet. 1993, 2:2037-2042.
52. Hewitt J.E., Lyle R., Clark L.N., Valleley E.M., Wright T.J., Wijmenga C., van Deutekom J.C., Francis F., Sharpe P.T., Hofker M., et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 1994, 3:1287-1295.
53. Gabellini D., D'Antona G., Moggio M., Prelle A., Zecca C., Adami R., Angeletti B., Ciscato P., Pellegrino M.A., Bottinelli R., Green M.R., Tupler R. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006, 439:973-977.
54. Yip D.J., Picketts D.J. Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation. FEBS Lett. 2003, 537:133-138.
55. Bosnakovski D., Xu Z., Gang E.J., Galindo C.L., Liu M., Simsek T., Garner H.R., Agha-Mohammadi S., Tassin A., Coppee F., Belayew A., Perlingeiro R.R., Kyba M. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 2008, 27:2766-2779.
56. Zerylnick C., Torroni A., Sherman S.L., Warren S.T. Normal variation at the myotonic dystrophy locus in global human populations. Am. J. Hum. Genet. 1995, 56:123-130.
57. Cho D.H., Tapscott S.J. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim. Biophys. Acta 2007, 1772:195-204.
58. Thornell L.E., Lindstom M., Renault V., Klein A., Mouly V., Ansved T., Butler-Browne G., Furling D. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Neuropathol. Appl. Neurobiol. 2009, 35:603-613.
59. Bigot A., Klein A.F., Gasnier E., Jacquemin V., Ravassard P., Butler-Browne G., Mouly V., Furling D. Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells. Am. J. Pathol. 2009, 174:1435-1442.
60. Timchenko N.A., Iakova P., Cai Z.J., Smith J.R., Timchenko L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol. 2001, 21:6927-6938.
61. Furling D., Coiffier L., Mouly V., Barbet J.P., St Guily J.L., Taneja K., Gourdon G., Junien C., Butler-Browne G.S. Defective satellite cells in congenital myotonic dystrophy. Hum. Mol. Genet. 2001, 10:2079-2087.
62. Pelletier R., Hamel F., Beaulieu D., Patry L., Haineault C., Tarnopolsky M., Schoser B., Puymirat J. Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol. Dis. 2009, 36:181-190.
63. Furling D., Lam le T., Agbulut O., Butler-Browne G.S., Morris G.E. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am. J. Pathol. 2003, 162:1001-1009.
64. Storbeck C.J., Drmanic S., Daniel K., Waring J.D., Jirik F.R., Parry D.J., Ahmed N., Sabourin L.A., Ikeda J.E., Korneluk R.G. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR. Hum. Mol. Genet. 2004, 13:589-600.
65. Bulfield G., Siller W.G., Wight P.A., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 1984, 81:1189-1192.
66. White R.B., Bierinx A.S., Gnocchi V.F., Zammit P.S. Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev. Biol. 2010, 10:21.
67. Lepper C., Conway S.J., Fan C.M. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 2009, 460:627-631.
68. Kinali M., Arechavala-Gomeza V., Feng L., Cirak S., Hunt D., Adkin C., Guglieri M., Ashton E., Abbs S., Nihoyannopoulos P., Garralda M.E., Rutherford M., McCulley C., Popplewell L., Graham I.R., Dickson G., Wood M.J., Wells D.J., Wilton S.D., Kole R., Straub V., Bushby K., Sewry C., Morgan J.E., Muntoni F. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 2009, 8:918-928.